The University of California, Irvine is a public land-grant research university in Irvine, California.

During the past decade, University of California - Irvine conducted 300 clinical trials. In the 10-year time frame, 300 clinical trials started and 109 clinical trials were completed, i.e. on average, 36.3% percent of trials that started reached the finish line to date. In the past 5 years, 156 clinical trials started and 74 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California - Irvine" #1 sponsor was "University of California, Irvine" with 73 trials, followed by "Pfizer" with 8 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Massachusetts General Hospital" with 7 trials sponsored and "Alzheimer's Disease Cooperative Study (ADCS)" with 7 trials sponsored. Other sponsors include 359 different institutions and companies that sponsored additional 250 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California - Irvine" #1 collaborator was "University of California, Irvine" with 21 trials as a collaborator, "National Institute on Aging (NIA)" with 17 trials as a collaborator, "National Eye Institute (NEI)" with 7 trials as a collaborator, "University of California, Los Angeles" with 7 trials as a collaborator and "University of California, San Francisco" with 7 trials as a collaborator. Other collaborators include 381 different institutions and companies that were collaborators in the rest 258 trials.

According to Clinical.Site data, the most researched conditions in "University of California - Irvine" are "Amyotrophic Lateral Sclerosis" (16 trials), "Alzheimer's Disease" (13 trials), "Alzheimer Disease" (10 trials), "Schizophrenia" (9 trials) and "Alopecia Areata" (7 trials). Many other conditions were trialed in "University of California - Irvine" in a lesser frequency.

Most popular intervention types in "University of California - Irvine" are "Drug" (265 trials), "Other" (62 trials), "Device" (53 trials), "Biological" (49 trials) and "Behavioral" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (90 trials), "Carboplatin" (7 trials), "Amivantamab" (6 trials), "Pemetrexed" (6 trials) and "Lazertinib" (5 trials). Other intervention names were less common.

The vast majority of trials in "University of California - Irvine" are 425 trials for "All" genders, 31 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "University of California - Irvine". undefined are not yet recruiting, 107 are recruiting, 60 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 205 completed trials in University of California - Irvine, 2 suspended trials, and 58 terminated clinical trials to date.

Out of the total trials that were conducted in University of California - Irvine, 56 "Phase 1" clinical trials were conducted, 163 "Phase 2" clinical trials and 121 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 86 trials that are defined as “Not Applicable".

University of California - Irvine has several departments that took part in Clinical trials: "Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center" - 76 trials, "UC Irvine Dermatology Clinical Research Center" - 15 trials, "Center for Functional Onco-Imaging, University of California" - 5 trials, "University of California Irvine Department of Neurology" - 3 trials, "Pediatric Exercise and Genomics Research Center, University of California, Irvine" - 3 trials, "Department of Pediatrics" - 2 trials